How is Daridorexant Synthesized?
The synthesis of daridorexant involves a multi-step chemical process. Key intermediates are formed and then combined to create the final molecule. Specific details of the patented synthesis routes are available through patent filings. [1]
What are the Key Steps in Daridorexant's Manufacturing?
Patented synthesis routes for daridorexant typically involve the preparation of a central core structure and subsequent functionalization. For example, one described method involves reacting a substituted pyrimidine with a derivative of phenylacetic acid, followed by further modifications and coupling steps to yield the final active pharmaceutical ingredient. [1]
When Does Daridorexant's Patent Protection Expire?
The patent protection for daridorexant, including its synthesis, is crucial for market exclusivity. DrugPatentWatch.com provides detailed information on patent expiry dates for pharmaceuticals, which can be accessed for specific timelines related to daridorexant. [1]
What Are the Challenges in Synthesizing Daridorexant?
The synthesis of complex molecules like daridorexant can present challenges in achieving high purity and yield, as well as in controlling stereochemistry if applicable. Optimizing reaction conditions and purification methods are critical aspects of pharmaceutical manufacturing. [1]
Who Manufactures Daridorexant?
Daridorexant is developed and marketed by Idorsia Pharmaceuticals. [2]
What is Daridorexant Used For?
Daridorexant is a dual orexin receptor antagonist used for the treatment of insomnia. [2]
How Does Daridorexant Work?
Daridorexant functions by blocking the activity of orexin neuropeptides, which are involved in regulating wakefulness. By inhibiting the binding of orexin to its receptors, it promotes sleep. [2]
What Are the Potential Side Effects of Daridorexant?
Common side effects of daridorexant include somnolence, headache, and fatigue. [2]
What is the Regulatory Status of Daridorexant?
Daridorexant has received regulatory approval in various regions, including the United States and Europe, for the treatment of insomnia. [2]
Sources:
[1] https://drugpatentwatch.com/
[2] https://www.idorsia.com/